These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 18367580)

  • 1. Comparison of serum humoral responses induced by oral immunization with the hepatitis B virus core antigen and the cholera toxin B subunit.
    Broos K; Janssens ME; De Goeyse I; Vanlandschoot P; Leroux-Roels G; Geysen D; Guisez Y
    Clin Vaccine Immunol; 2008 May; 15(5):852-8. PubMed ID: 18367580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of humoral and CD4+ cellular responses after genetic immunization with retroviral vectors expressing different forms of the hepatitis B virus core and e antigens.
    Sällberg M; Townsend K; Chen M; O'Dea J; Banks T; Jolly DJ; Chang SM; Lee WT; Milich DR
    J Virol; 1997 Jul; 71(7):5295-303. PubMed ID: 9188598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of HBs, HBc, and frCP virus-like particles for expression of human papillomavirus 16 E7 oncoprotein epitopes.
    Pumpens P; Razanskas R; Pushko P; Renhof R; Gusars I; Skrastina D; Ose V; Borisova G; Sominskaya I; Petrovskis I; Jansons J; Sasnauskas K
    Intervirology; 2002; 45(1):24-32. PubMed ID: 11937768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hepatitis B virus core and e antigens elicit different Th cell subsets: antigen structure can affect Th cell phenotype.
    Milich DR; Schödel F; Hughes JL; Jones JE; Peterson DL
    J Virol; 1997 Mar; 71(3):2192-201. PubMed ID: 9032353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction and immunological evaluation of multivalent hepatitis B virus (HBV) core virus-like particles carrying HBV and HCV epitopes.
    Sominskaya I; Skrastina D; Dislers A; Vasiljev D; Mihailova M; Ose V; Dreilina D; Pumpens P
    Clin Vaccine Immunol; 2010 Jun; 17(6):1027-33. PubMed ID: 20410327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Hepatitis B Virus Core Variants that Expose Foreign C-Terminal Insertions on the Outer Surface of Virus-Like Particles.
    Dishlers A; Skrastina D; Renhofa R; Petrovskis I; Ose V; Lieknina I; Jansons J; Pumpens P; Sominskaya I
    Mol Biotechnol; 2015 Dec; 57(11-12):1038-49. PubMed ID: 26446016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of HBc virus-like particles as modular nanocarrier by intein-mediated trans-splicing.
    Wang Z; Tang S; Yue N; Qian Z; Zhou S
    Biochem Biophys Res Commun; 2021 Jan; 534():891-895. PubMed ID: 33213839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically engineered fusion of allergen and viral-like particle induces a more effective allergen-specific immune response than a combination of them.
    Sani MZ; Bargahi A; Momenzadeh N; Dehghani P; Moghadam MV; Maleki SJ; Nabipour I; Shirkani A; Akhtari J; Hesamizadeh K; Heidari S; Omrani F; Akbarzadeh S; Mohammadi M
    Appl Microbiol Biotechnol; 2021 Jan; 105(1):77-91. PubMed ID: 33215260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA immunization with fusion of CTLA-4 to hepatitis B virus (HBV) core protein enhanced Th2 type responses and cleared HBV with an accelerated kinetic.
    Yin Y; Wu C; Song J; Wang J; Zhang E; Liu H; Yang D; Chen X; Lu M; Xu Y
    PLoS One; 2011; 6(7):e22524. PubMed ID: 21799884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity.
    Schödel F; Moriarty AM; Peterson DL; Zheng JA; Hughes JL; Will H; Leturcq DJ; McGee JS; Milich DR
    J Virol; 1992 Jan; 66(1):106-14. PubMed ID: 1370083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus core and e antigen: immune recognition and use as a vaccine carrier moiety.
    Schödel F; Peterson D; Milich D
    Intervirology; 1996; 39(1-2):104-10. PubMed ID: 8957676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune response induced by immunization with Hepatitis B virus core DNA isolated from chronic active hepatitis patients.
    Lee YS; Yoon SJ; Kwon TK; Kim YH; Woo JH; Suh MH; Suh SI; Baek WK; Kim HJ; Ahn SY; Choe BK; Park JW
    Immunol Lett; 2001 Aug; 78(1):13-20. PubMed ID: 11470146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of meningococcal polysaccharide conjugate vaccine that can elicit long-lasting and strong cellular immune response with hepatitis B core antigen virus-like particles as a novel carrier protein.
    Xu L; Li Z; Su Z; Yang Y; Ma G; Yu R; Zhang S
    Vaccine; 2019 Feb; 37(7):956-964. PubMed ID: 30655174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of chimeric HBc proteins with epitopes in E.coli: formation of virus-like particles and a potent inducer of antigen-specific cytotoxic immune response and anti-tumor effect in vivo.
    Zhang Y; Song S; Liu C; Wang Y; Xian X; He Y; Wang J; Liu F; Sun S
    Cell Immunol; 2007 May; 247(1):18-27. PubMed ID: 17707782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HBcAg produced in transgenic tobacco triggers Th1 and Th2 response when intramuscularly delivered.
    Pyrski M; Rugowska A; Wierzbiński KR; Kasprzyk A; Bogusiewicz M; Bociąg P; Samardakiewicz S; Czyż M; Kurpisz M; Pniewski T
    Vaccine; 2017 Oct; 35(42):5714-5721. PubMed ID: 28917537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chimeric Hepatitis B core virus-like particles harboring SARS-CoV2 epitope elicit a humoral immune response in mice.
    Sazegari S; Akbarzadeh Niaki M; Afsharifar A; Niazi A; Derakhshandeh A; Moradi Vahdat M; Hemmati F; Eskandari MH
    Microb Cell Fact; 2023 Feb; 22(1):39. PubMed ID: 36841778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine delivery system for tuberculosis based on nano-sized hepatitis B virus core protein particles.
    Dhanasooraj D; Kumar RA; Mundayoor S
    Int J Nanomedicine; 2013; 8():835-43. PubMed ID: 23486691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Humoral and cellular immunogenecity of genetic vaccine on core gene of hepatitis B virus in mice].
    Huang Z; Lu S; Liu N
    Zhonghua Yi Xue Za Zhi; 1999 Jun; 79(6):456-9. PubMed ID: 11715443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and immunoactivity of chimeric particulate antigens of receptor binding site-core antigen of hepatitis B virus.
    Yang HJ; Chen M; Cheng T; He SZ; Li SW; Guan BQ; Zhu ZH; Gu Y; Zhang J; Xia NS
    World J Gastroenterol; 2005 Jan; 11(4):492-7. PubMed ID: 15641132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silica nanoparticles as the adjuvant for the immunisation of mice using hepatitis B core virus-like particles.
    Skrastina D; Petrovskis I; Lieknina I; Bogans J; Renhofa R; Ose V; Dishlers A; Dekhtyar Y; Pumpens P
    PLoS One; 2014; 9(12):e114006. PubMed ID: 25436773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.